Shares in clinical dermatology company Botanix halted ahead of FDA decision for sweat-stopper gel

‘Transformative event’: Clinical dermatology firm Botanix gets US FDA nod for sweat-stopper gel

thewest.com.au - 20/Jun 02:30

Clinical dermatology company Botanix has secured US Food and Drug Administration approval for its gel aimed at treating excessive sweating.

Perth biotech Botanix to raise $70m following FDA nod for sweat-stopper gel

thewest.com.au - 21/Jun 03:24

Biotech Botanix says it has received firm commitments to raise $70 million from institutional investors just a day after it received US Food and Drug...

FDA Approves Sofdra (sofpironium) Topical Gel for the Treatment of Primary Axillary Hyperhidrosis

drugs.com - 20/Jun 04:06

Philadelphia and Phoenix US, 20 June 2024 -- Clinical dermatology company, Botanix Pharmaceuticals Ltd. (ASX:BOT, Botanix or the Company), is pleased...

ASX Health Stocks: Control Bionics surges over 50pc after TGA approval of DROVE wheelchair

stockhead.com.au - 20/Jun 00:53

Control Bionics' shares surge after TGA approval, and Botanix Pharma granted US FDA approval for Sofdra (sofpironium) gel. ...

Imricor starts global trial for US FDA approval

stockhead.com.au - 21/Jun 04:48

Imricor’s VISABL-AFL global clinical trial supporting US Food and Drug Administration (FDA) approval has kicked off. ...

Genting and TauRx applying for UK, US regulators' approval for Alzheimer's drug

nst.com.my - 20/Jun 21:55

KUALA LUMPUR: Genting Bhd, along with its partner TauRx Pharmaceuticals Ltd., is currently seeking approval from both the United Kingdom's Medicines...

Harmony Biosciences Receives U.S. Food And Drug Administration Approval for Wakix (pitolisant) In Pediatric Patients With Narcolepsy

drugs.com - 24/Jun 23:06

PLYMOUTH MEETING, Pa., June 24, 2024 /PRNewswire/ -- Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration...

Synaptogenix gets US FDA authorization of IND application for clinical trial for Bryostatin─1 to treat multiple sclerosis

pharmabiz.com - 01/Jul 00:00

Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, announced that the Food & Drug...

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

asianewsday.com - 21/Jun 20:29

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

Monthly News Roundup - June 2024

drugs.com - 30/Jun 00:06

FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s...

Rubriques :